Interventional technology provider AngioDynamics has signed a worldwide agreement with Transonic Systems for the distribution of the Ithaca, NY-based firm's Endovascular Flowmeter system, which measures flow rates in the bloodstream. AngioDynamics will market the system under its own brand name as Flowmeter and the Reo-Cath dilution flow catheter, according to AngioDynamics parent E-Z-EM of Queensbury, NY.
Under the five-year agreement, AngioDynamics will distribute both products globally, with exclusive distribution rights in the U.S. Both have received clearance by the Food and Drug Administration and comparable international agencies, according to E-Z-EM.
By AuntMinnie.com staff writersDecember 13, 2002
Related Reading
AngioDynamics debuts new embolic material, November 8, 2002
AngioDynamics debuts new biliary stent, May 11, 2001
Copyright © 2002 AuntMinnie.com
